On March 6, 2024, Perspective Therapeutics, Inc. closed the transaction. The company will issue securities pursuant to exemption provided under Regulation D from 9 investors.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
76.3 USD | +0.52% | +0.89% | +22.90% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
76.3 USD | +0.52% | +0.89% | 5.26B | ||
1.715 USD | -4.72% | -5.52% | 1.06B | ||
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.90% | 5.26B | |
-1.29% | 12.64B | |
-0.47% | 8.37B | |
+5.68% | 5.37B | |
-2.03% | 4.58B | |
-53.58% | 3.16B | |
+19.30% | 2.89B | |
-8.42% | 2.22B | |
-3.55% | 1.91B | |
+5.37% | 1.65B |
- Stock Market
- Equities
- LNTH Stock
- News Lantheus Holdings, Inc.
- Perspective Therapeutics, Inc. announced that it has received $87.409482 million in funding from Lantheus Holdings, Inc. and other investors